Stomach cancer shot could replace IV drip in major trial
NCT ID NCT07449780
First seen Mar 04, 2026 · Last updated May 14, 2026 · Updated 12 times
Summary
This study tests if an immunotherapy drug (AK104) given as a shot under the skin works as well as the same drug given through an IV drip, when both are combined with chemotherapy. About 422 people with advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery will take part. The goal is to see if the shot is a safe and effective option that is easier for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.